Related Experiment Video
Updated: Jul 1, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Optimizing diabetes management through glucose profiling: a case-based approach
1David Geffen School of Medicine at UCLA, Los Angeles, CA 91037, USA. dstreja@ucla.edu
Primary Care Diabetes
|September 13, 2008
Summary
Tight glucose control is crucial for preventing diabetes complications. Monitoring blood glucose after meals, rather than just fasting, may improve glycemic control and outcomes in type 2 diabetes.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Diabetes Management
Background:
- Tight glycemic control is essential for preventing microvascular complications in diabetes.
- Postprandial hyperglycemia is increasingly linked to macrovascular complications.
- Current therapies often lack personalization for individual glucose excursion patterns.
Observation:
- Postprandial self-monitoring of blood glucose (SMBG) values show a stronger correlation with HbA1c than fasting values.
- Studies involving pregnancies complicated by diabetes show improved glucose control and outcomes with mealtime SMBG.
- This approach highlights the importance of individualized glucose monitoring.
Findings:
- Mealtime SMBG is a valuable tool for assessing glycemic control.
- Individualized glucose monitoring patterns can be more informative than fasting measurements.
- Effective glucose management requires attention to postprandial glucose levels.
Implications:
- Adopting a mealtime SMBG model in type 2 diabetes management could lead to better glycemic control.
- Personalized glucose monitoring strategies may enhance treatment efficacy.
- Improved glucose control can reduce the risk of both microvascular and macrovascular complications.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...